TY  - JOUR
AU  - Dominguez-Molina, Beatriz
AU  - Tarancon-Diez, Laura
AU  - Hua, Stephane
AU  - Abad-Molina, Cristina
AU  - Rodriguez-Gallego, Esther
AU  - Machmach, Kawthar
AU  - Vidal, Francesc
AU  - Tural, Cristina
AU  - Moreno, Santiago
AU  - Goni, Maria Jose
AU  - de Arellano, Elena Ramirez
AU  - del Val, Margarita
AU  - Gonzalez-Escribano, Maria Francisca
AU  - Del Romero, Jorge
AU  - Rodriguez, Carmen
AU  - Capa, Laura
AU  - Viciana, Pompeyo
AU  - Alcami, Jose
AU  - Yu, Xu G.
AU  - Walker, Bruce D.
AU  - Leal, Manuel
AU  - Lichterfeld, Mathias
AU  - Ruiz-Mateos, Ezequiel
AU  - Spanish AIDS Res Network HIV-Contr
PY  - 2017
DO  - 10.1093/cid/ciw833
SN  - 1058-4838
UR  - http://hdl.handle.net/10668/18938
T2  - Clinical infectious diseases
AB  - Background. Human immunodeficiency virus type 1 (HIV-1) controllers maintain HIV-1 viremia at low levels (normally 500 cells/mm(3) for more than 7 years after HIV-1 diagnosis) vs non-LTNP-Cs who developed CD4+ T-cell counts
LA  - en
PB  - Oxford univ press inc
KW  - HIV controllers
KW  - progression
KW  - HLA-B(star)57
KW  - IFNL4
KW  - Plasmacytoid dendritic cells
KW  - Elite
KW  - Il28b
KW  - Clearance
KW  - Therapy
TI  - HLA-B(star)57 and IFNL4-Related Polymorphisms Are Associated With Protection Against HIV-1 Disease Progression in Controllers
TY  - research article
VL  - 64
ER  -